New analysis backs use of Takeda’s Entyvio

18th October 2017 Uncategorised 0

Takeda has presented data from a post-hoc analysis showing signs of early symptomatic improvement in patients with ulcerative colitis or Crohn’s disease taking Entyvio.

More: New analysis backs use of Takeda’s Entyvio
Source: News